Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jens V. Stein, Marta López-Fraga, Fernando A. Elustondo, Carla E. Carvalho-Pinto, Dolores Rodríguez, Ruth Gómez-Caro, Joan de Jong, Carlos Martínez-A, Jan Paul Medema, Michael Hahne
Published in Volume 109, Issue 12
J Clin Invest. 2002; 109(12):1587–1598 doi:10.1172/JCI15034
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

B and T cell homeostasis in APRIL Tg mice. (a) Unaltered spleen weight in APRIL Tg mice. Spleen weight of mice was measured at the age of 6–12 weeks (n = 12). (b) Unaltered splenocyte and peripheral lymph node cell number in APRIL Tg mice. Splenocyte number was determined in 6- to 12-week-old mice (n = 11). Data represent the mean ± SD. (c) Evaluation of B cell percentage (B220+ cells) in spleen, mesenteric lymph nodes (MLN), Peyer’s patches (PP), and peripheral lymph nodes (PLN) (n = 10). (d) Percentage of CD4+ and CD8+ T cell populations in peripheral lymph nodes of APRIL Tg mice (n = 10; 6–12 weeks old). (e) Comparison of absolute B and T cell numbers in peripheral lymph nodes (n = 10). Data are the mean ± SM. The statistical significance of the data was determined using ANOVA. P > 0.05 is considered insignificant, P < 0.05 significant, P < 0.01 very significant, and P < 0.0001 extremely significant. Co, control.